• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$37.55 -$0.05 (-0.13%)

REAL-TIME: Last trade at

Merck & Co., Inc.

NYSE:MRK

Jump to this page for:

Related Resources

A Detailed Overview Of The Best Dogs Of The Dow Jones In May 2012

5/28/2012 by Seeking Alpha

Insurance For Health Care Stocks

5/28/2012 by Seeking Alpha

Billionaire Phillip Frost: A Case Study In Synergy

5/28/2012 by Trefis

Abbott: Don't Miss Out On Its High Growth

5/25/2012 by Seeking Alpha

Pfizer: A $22 Stock Worth $25

5/25/2012 by Seeking Alpha

Emergent, Pfizer, Abbott Looking Strong In Their Fields

5/25/2012 by Trefis

The Meaningless Drug Approval That Could Cost the Industry Billions

5/25/2012 by DailyFinance

Abbott Wants To Extract More From Humira While Pfizer Slogs Along With Lipitor

5/25/2012 by Trefis

Pfizer: Don't Overlook This $22 Gem

5/24/2012 by Seeking Alpha

Johnson & Johnson: An Uncommon Opportunity

5/24/2012 by Seeking Alpha

FDA Nod for Merck Drug Label Update - Analyst Blog

5/24/2012 by Nasdaq

Abbott Aims Pediatric Nutritional Market With New Beverage

5/24/2012 by Trefis

Hide from Europe's mess with dividend stocks

5/23/2012 by CNN Money

Why Abbott Is A Buy After The Lawsuit

5/23/2012 by Seeking Alpha

Pharma Updates: Pfizer Recalls Advil & Merck’s Propecia Causes Furor

5/23/2012 by Trefis

Abbott Updates: Niaspan Losing Vigor, But Nutritionals Going Strong

5/22/2012 by Trefis

Too Little, Too Late for Achillion?

5/22/2012 by DailyFinance

4-Star Stocks Poised to Pop: Merck

5/21/2012 by DailyFinance

J&J's Simponi Helps Colitis Patients In Clinical Trial

5/21/2012 by Smart Money

Should Investors Worry About Arena's Offering?

5/17/2012 by DailyFinance

5 Pharmaceutical Stocks With Significant Exposure to Europe

5/17/2012 by DailyFinance

Pfizer’s Pipeline: Drugs To Watch Post Lipitor

5/17/2012 by Trefis

2 Reasons That Cystic Fibrosis Trumps Hep C

5/16/2012 by DailyFinance

The Dow Couldn't Hold Back These 4 Stocks

5/16/2012 by DailyFinance

This Biotech's for Sale! Reportedly.

5/15/2012 by DailyFinance

Has Ariad Pharmaceuticals Become the Perfect Stock?

5/15/2012 by DailyFinance

Johnson & Johnson’s CEO Looks To Bolster Cardiology Devices Segment Through Acquisitions

5/15/2012 by Trefis

Johnson & Johnson’s CEO Looks To Bolster Cardiology Devices Segment Through Acquisitions

5/15/2012 by Trefis

Investors Seeking Defensive Stocks Where 3% to Over 5% Dividends Rule!

5/14/2012 by 247wallst

4 Winners As the Dow Gets Pummeled

5/14/2012 by DailyFinance

The Dow Makes It 8 Drops in 9 Days

5/14/2012 by DailyFinance

Abbott Settles Depakote Suit For $1.5 billion; Urges FDA To Block Generics

5/11/2012 by Trefis

Abbott Settles Depakote Suit For $1.5 billion; Urges FDA To Block Generics

5/11/2012 by Trefis

Why Apple Should Replace Cisco in the Dow

5/11/2012 by Minyanville

Simcere Misses on all Fronts - Analyst Blog

5/10/2012 by Nasdaq

How High Can Vertex Pharmaceuticals Fly?

5/10/2012 by DailyFinance

Has XOMA Become the Perfect Stock?

5/10/2012 by DailyFinance

This Biotech Is No One-Trick Pony

5/10/2012 by DailyFinance

Pfizer To Invest $3 Billion In Indonesia; Lost Opportunity In Tofacitinib

5/10/2012 by Trefis

JNJ Updates: Acquisition In China, FDA Approvals & Lawsuits

5/9/2012 by Trefis
See More Articles...